A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes.

TitleA newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes.
Publication TypeJournal Article
Year of Publication2021
AuthorsPerez VA, Husain S, Magro CM, Strom MA, Williams KM, Levin LE
JournalPediatr Dermatol
Volume38
Issue1
Pagination239-241
Date Published2021 Jan
ISSN1525-1470
KeywordsBlood Glucose, Blood Glucose Self-Monitoring, Child, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin Infusion Systems
Abstract

Continuous subcutaneous insulin infusion (CSII), or insulin pumps, with or without continuous glucose monitoring (CGM) devices have become the standard of care for patients with type 1 diabetes. While increasingly popular, a wide range of reported skin reactions to CSII and CGM devices was found. We present this case of a pyogenic granuloma-like neutrophilic and granulomatous response to an insulin pump to increase awareness of a previously uncharacterized cutaneous adverse reaction at insulin pump infusion sites.

DOI10.1111/pde.14438
Alternate JournalPediatr Dermatol
PubMed ID33169884
Related Faculty: 
Cynthia M. Magro, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700